Meetings, Workshops & Trainings
FDA Safety Communications
December 17, 2021
Learn More
FDA Advisory Committee Meetings
Learn More

Latest Publications & Presentations
Publication
01/24/2023
Data on angioedema risk among sacubitril-valsartan (SV) users in real-world settings are limited. We sought to evaluate the risk of angioedema among SV new users compared with angiotensin-…
Publication
12/01/2022
We examined patterns in care for individuals treated for latent TB infection (LTBI) in the US Food and Drug Administration's Sentinel System.
Using administrative claims data, we…
